Company

Therna Biosciences, Inc.

Therna Biosciences develops programmable RNA therapeutics using generative design technology.

About

Therna Biosciences uses a generative RNA design platform to develop custom RNA sequences for therapeutic applications. Its work targets diseases including cancer, genetic disorders, and infectious diseases. Founded in 2023, the company is based in California, US. In August 2025, it raised USD 9.21 million in seed funding from AIX Ventures, Pear VC, Fusion Fund, and other investors.

1Funding rounds

3Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in